INTERLEUKIN GENETICS INC
10-Q, EX-27, 2000-11-14
MEDICAL LABORATORIES
Previous: INTERLEUKIN GENETICS INC, 10-Q, 2000-11-14
Next: ARCH COAL INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE SEPTEMBER 30, 2000 BALANCE SHEET AND THE INCOME STATEMENT FOR THE NINE
MONTHS ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         274,217
<SECURITIES>                                 3,970,870
<RECEIVABLES>                                  200,782
<ALLOWANCES>                                    66,090
<INVENTORY>                                          0
<CURRENT-ASSETS>                             4,612,556
<PP&E>                                         769,578
<DEPRECIATION>                                 630,376
<TOTAL-ASSETS>                               4,751,758
<CURRENT-LIABILITIES>                          986,001
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    28,385,492
<OTHER-SE>                                       1,484
<TOTAL-LIABILITY-AND-EQUITY>                 4,751,758
<SALES>                                         38,141
<TOTAL-REVENUES>                                38,141
<CGS>                                           36,423
<TOTAL-COSTS>                                1,128,016
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,957
<INCOME-PRETAX>                            (1,130,255)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,130,255)
<EPS-BASIC>                                      (.06)
<EPS-DILUTED>                                    (.06)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission